Examination of intrinsic sulfonamide resistance in Bacillus anthracis: A novel assay for dihydropteroate synthase

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 5, 2008, Pages 848-853

  Valderas, Michelle Wright ^a   Andi, Babak ^b   Barrow, William W ^a   Cook, Paul F ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

6 Hydroxymethyl 7,8 dihydropterin diphosphate; Coupled spectrophotometric assay; Dihydropteroate; Dihydropteroate synthase; para Aminobenzoic acid; Sulfonamide

Indexed keywords

4 AMINOBENZOIC ACID; 6 HYDROXYMETHYL 7,8 DIHYDROPTERIN DIPHOSPHATE; 6 PHOSPHOFRUCTOKINASE; DAPSONE; DIHYDROPTEROATE SYNTHASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; MAGNESIUM; PTERIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SULFADIAZINE; SULFAFURAZOLE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFATHIAZOLE; SULFONAMIDE; TRIOSE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS ANTHRACIS; BINDING AFFINITY; CATALYSIS; DRUG PROTEIN BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

4-AMINOBENZOIC ACID; BACILLUS ANTHRACIS; CATALYSIS; DIHYDROPTEROATE SYNTHASE; DIPHOSPHATES; DRUG RESISTANCE, BACTERIAL; FRUCTOSE-BISPHOSPHATE ALDOLASE; FRUCTOSEPHOSPHATES; GLYCEROLPHOSPHATE DEHYDROGENASE; KINETICS; MAGNESIUM COMPOUNDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NAD; PHOSPHORIC ACIDS; PHOSPHOTRANSFERASES; PTERINS; RECOMBINANT PROTEINS; SULFONAMIDES; TRIOSE-PHOSPHATE ISOMERASE;

BACILLUS ANTHRACIS;

EID: 45049086683     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.02.003     Document Type: Article

References (23)

1. Hartman P.G. Molecular aspects and mechanism of action of dihydrofolate reductase inhibitors. J. Chemother. 5 (1993) 369-376
2. Quinlivan E.P., McPartlin J., Weir D.G., and Scott J. Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J. 14 (2000) 2519-2524
3. Skold O. Sulfonamide resistance: mechanisms and trends. Drug Resist. Updat. 3 (2000) 155-160
4. Brown G.M. The biosynthesis of folic acid. II. Inhibition by sulfonamides. J. Biol. Chem. 237 (1962) 536-540
5. Roland S., Ferone R., Harvey R.J., Styles V.L., and Morrison R.W. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase. J. Biol. Chem 254 (1979) 10337-10345
6. Swedberg G., Castensson S., and Skold O. Characterization of mutationally altered dihydropteroate synthase and its ability to form a sulfonamide-containing dihydrofolate analog. J. Bacteriol. 137 (1979) 129-136
7. Woods D.D. The relation of p-aminobenzoic acid to the mechanism of action of sulphanilamide. Br. J. Exp. Pathol. 21 (1940) 74-90
8. Barrow E.W., Bourne P.C., and Barrow W.W. Functional cloning of Bacillus anthracis DHFR and confirmation of natural resistance to trimethoprim. Antimicrob. Agents Chemother. 48 (2004) 4643-4649
9. Pluvinage B., Dairou J., Possot O.M., Martins M., Fouet A., Dupret J.-M., and Rodrigues-Lima F. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance. Biochemistry 46 (2007) 7069-7078
10. Valderas M.W., and Barrow W.W. Genetic basis for sulfonamide resistance in Bacillus anthracis. Microb. Drug Resist. 13 (2007) 11-20
11. Walter R.D., and Konigk E. 7,8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi. Methods enzymol. 66 (1980) 564-570
12. Aspinall T.V., Joynson D.H., Guy E., Hyde J.E., and Sims P.F. The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J. Infect. Dis. 185 (2002) 1637-1643
13. Bertagnolli B.L., and Cook P.F. Kinetic mechanism of pyrophosphate-dependent phosphofructokinase from Propionibacterium freudenreichii. Biochemistry 23 (1984) 4101-4108
14. Zawadzke L.E., Timothy D.H., and Walsh C.T. Existence of two d-alanine:d-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the Ddl and DdlB enzymes. Biochemistry 30 (1991) 1673-1682
15. Odendaal M.S., Pieterson P.M., deMos V., and Botha A.D. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. Onderstepoort J. Vet. Res. 58 (1991) 17-19
16. m. Antimicrob. Agents Chemother. 45 (2001) 805-809
17. Schomburg I., Hofmann O., Bänsch C., Chang A., and Schomburg D. Enzyme data and metabolic information: BRENDA, a resource for research in biology, biochemistry, and medicine. Gene Funct. Dis. 3-4 (2000) 109-118
18. Babaoglu K., Qi J., Lee R.E., and White S.W. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis; mechanism and novel inhibitor design. Structure (Camb) 12 (2004) 1705-1717
19. Achari A., Somers D.O., Champness J.N., Bryant P.K., Rosemond J., and Stammers D.K. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat. Struct. Biol. 4 (1997) 490-497
20. Lever Jr. O.W., Bell L.N., McGuire H.M., and Ferone R. Monocyclic pteridine analogues. Inhibition of Escherichia coli dihydropteroate synthase by 6-amino-5-nitrosoisocytosines. J. Med. Chem. 28 (1985) 1870-1874
21. T. Stachyra, J. Biton, In international publication number WO 03/012132 A2 (Aventis, Pharma, Antony, France; 2003).
22. Fernley R.T., Iliades P., and Macreadie I. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors. Anal. Biochem. 360 (2007) 227-234
23. Bennett B.C., Xu H., Simmerman R.F., Lee R.E., and Dealwis C.G. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase. J. Med. Chem. 50 (2007) 4374-4381